Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Pflugers Arch. 2014 Feb 25;466(4):757–765. doi: 10.1007/s00424-014-1454-x

Table 2.

Drug Candidates with Possible Neuroprotective Effects

Drug Candidate Pathways Inhibited IC50 -T channel Neuroprotection
A1048400 T-Type and N-Type 1.2-4.6μM ?
KYS05044 T-Type (CaV3.1, CaV3.2) 1μM ?
ML218 T-Type (CaV3.1-CaV3.3) 150-310nM Y
NNC 55-0396 T-Type 7μM Y
RQ-00311610 T-Type 110-170nM ?
TTA-A2 T-Type (CaV3.1-3.3) 50-100nM Y
TTA-P2 T-Type 22nM ?
VH04 T-Type (CaV3.1) 100nM ?
Z941/944 T-Type 50-160nM Y